5 – Experimental design
Beyond numbers.
During this course, you will learn about statistics, yes, but my hope and goal for your experience in this class is much more than that: statistical reasoning. To have statistical reasoning skills, you need to be comfortable with the context of how data are acquired, ie, data acquisition. It’s not just about knowing how an instrument performs, eg, under or over the limits of quantification characteristics of the instrument lead to censored missing values, missing not at random (MNAR). In a broad stoke view, data are obtained from two kinds of studies: observational studies and experimental (manipulative) studies. what a correctly designed experiment can tell you about the world, and how a poorly designed experiment works against you. At the end of the semester, you should be familiar with the issues of Randomization, Control, Independence, and Replication.
The basics explained.
Experimental design is a discipline within statistics concerned with the analysis and design of experiments. Design is intended to help research create experiments such that cause and effect can be established from tests of the hypothesis. We introduced elements of experimental design in Chapter 2.4. I recommend a quick re-read: We talk about the different types of bias that can affect research. We also point out parts of the problem you’ll need to think about when planning a project, so you can avoid or reduce bias from the start.
Note 1: Just the highlights from Chapter 2.4: use randomization, blinding, and control measures in the study design. Different strategies may be needed depending on the type of bias.
Here, we expand our discussion of experimental design. We begin with review of definitions and an outline of an important concept in statistics. First, we need to be clear about why we measure or conduct experiments. We do so to collect data (datum is the singular) about a characteristic or trait from a population. Data are observations: they include observations and measurements from instruments. At their best, data are the “facts” of science.
Measurement, Observation, Variables, Values.
Measurement is how we as scientists acquire our data (Chapter 3.4). The process of measuring involves the assignment of numbers, codes, or labels to observations according to rules established prior to any data collection (Stevens 1946, Houle et al 2011). Observations refer to the units of measurement, whereas variables are the characteristics or traits that are measured. A value refers to the particular number, score, or label assigned to a particular sample for a variable. Variables are generic, the thing being measured, values are specific to the subject or sample being measured for the variable. Each discipline in biology has its own set of variables and samples may or may not have different values for each variable measured. Variables are summarized as a statistic (eg, the sample mean), which is a number taken to estimate a parameter, which pertains to the population. Variables and parameters in statistics were discussed in Chapter 3.4. Because numbers or scores or labels can be assigned according to different rules, this means that variables may be measured on different kinds of scales or data types. The different kinds of data types were presented in Chapter 3.1.
Missing values.
A missing value refers to lack of a value for an observation or variable (Chapter 3.5). Censored values, a type of missing value, include observations for which limited or partial information is available, eg, range, while a missing value lacks any information about the true value.
Missing values can affect analysis and many R algorithms are sensitive or may fail to run in the presence of missing values. Missing data may be of three kinds, and one of them, missing not at random (MNAR), can substantially influence the analysis. MNAR implies some observations are missing because of a systematic bias. Instrument limits of quantification are an example of systematic bias — for example, spectrophotometric absorbance readings of zero for a colorimetric assay (eg, Bradford protein assay) may not represent complete absence of the target, but rather, the lower detection limits of the instrument or the assay method (0.1 mg protein/mL in this case).
The other kinds of missing values are missing completely at random (MCAR) and missing at random (MAR). MCAR implies there is no association between any element of the experiment and the absence of a value. Analysis on MCAR data sets may support unbiased conclusions. MAR includes the random errors that occur during data acquisition: data may be lost because of operator error or power outage (shudder). Unlike MNAR, analysis of MAR, like MCAR data sets may still result in unbiased conclusions.
Note 2: The word “may” is doing some heavy lifting here; obviously, the size of the data set influences whether this claim holds.
One consequence of missing values — a decision how best to handle the lost information. The options are either pairwise deletion or listwise deletion. Listwise means the entire row, all variables, are lost for any record with one or more missing values. You recorded root length, stem length, numbers of secondary roots, time to germinate, but the SPAD meter failed and there is no chlorophyl reading for seedling #212? Sorry, the entire row is deleted. Optionally, the missing data is deleted pairwise — only chlorophyl reading for #212 is lost, all other variables remain.
Users of R will quickly learn some algorithms immediately fail to run if not instructed how to process missing values. In some cases, missing values can be replaced by imputed values.
Note 3: This being an introduction to applied biostatistics, we won’t dwell on the pros and cons of imputation. Instead, I point interested readers to two heavily cited articles: Schafer 1999; Schafer and Graham 2002.
Cause & Effect.
Observations or measurements gathered under controlled conditions (experiments) are essential if we are to answer questions about populations, to separate cause and effect, where one or more events is directly the result of another factor, as opposed to anecdote, a story about an event which, by itself, cannot be used to cause from association (eg, spurious correlations, see Ch 16.2). Recall that anecdotal evidence typically comes from personal experience, where observations may be obtained by non-systematic methods. Well designed experiments, in the classical sense, permit discrimination among competing hypotheses in large part because observations are collected according to strict rules. Well developed hypotheses tested by well-designed experiments permit ruling out alternative explanations (sensu Pratt [1964] strong inference). Observational studies, or epidemiology studies if we are talking about investigations of risk assessment, also may contribute to discussions of cause and effect (see history of smoking by Doll 1998).
Medicine is replete with stories about how a patient showed a particular set of symptoms, and how a physician applied a set of diagnostic protocols. An outcome was achieved, and the physician reports the outcome and circumstances related to the patient to her colleagues. This is an example of a case study, and the focus of investigation is the individual, the patient. The doctor’s report will sound like, “I tried the standard treatment given the diagnosis, and the patient’s symptoms diminished, but later returned. I tried a higher dose, but the patient’s symptoms persisted unabated.” No inferences are made to a wider set of individuals and the report is anecdotal. If observations are made on several patients, this may be a case series.
In ecology, a field biologist may notice a six-legged adult frog (Scott 1999, Alvarez et al 2021) — since frogs typically have four legs, the six-legged frog attracts the biologist’s eye and he jots down the circumstances in which the frog were found: relative humidity, air temperature, ground temperature, where the frogs was found (on lower leaf of a philodendron plant). A water source near where the frog was found is tested for pH with a meter the biologist carries, and a water sample is taken for later testing of herbicides. The frog is collected so that it can be checked for skin parasites. Upon further inspection, the frog did indeed have parasites known to cause deformities in other frog species. However, note that this example too, is a case study. Although the biologist makes additional observations, any conclusions about why the frog has six legs is anecdotal.
From these case studies, no conclusions can be drawn. We cannot say why the patient failed to respond to treatment, nor can we say why the frog has six legs. Why? Because these are singular events, and a variety of explanations can be given as to their causes — importantly, no controls are available, so there’s no way to distinguish among possibilities.
From such anecdotes, however, experiments can be designed. The physician may decide to recruit additional patients with the diagnosed illness and apply the standard treatment to see if her anecdote is a single, unique event, or more indicative of a problem with the treatment. The biologist may collect other frogs from the area near where he found the six-legged frog and check to see if they, too, have the parasites. If additional patients fail to respond to the treatment, then the singular even is more likely to be a phenomenon. If the normal frogs also have similar levels of the parasite then it is unlikely that these parasites caused the malformed frog. With this simple step (recruiting similar patients, finding additional frogs), we can begin to make inferences about cause and effect and in some cases, to generalize our findings.
This is the objective of most statistical procedures, the concept of sampling from a reference population and making distinctions between groups within the sample. The difference between observational and experimental studies then is how the subjects are selected with respect to the groups. In an experiment, the researcher controls and decides which subject receives the treatment, therefore, allocation to groups is manipulated by the researcher. In contrast, subjects included in an observational study have already been “assigned” to a group, but not by us. Assignment to groups, smokers or non smokers, Type II diabetes or no diabetes (etc.), is done by nature.
Now, I do not wish to imply that research that cannot be generalized back to a reference population are worthless. Far from it. In fact, there is a strong argument for specificity. For example, much basic biological research depends on work or model organisms, which in turn may be further partitioned into specific genetic lines (cf. discussion in Rothman et al 2013). And my goodness, what we have learned about the devastation to oceanic islands like Guam when the brown tree snake was introduced (Fritts and Rodda 1998). Strictly speaking, what has happened to Guam is a case history. But no one would argue that what has happened to Guam cannot happen to Hawaii and other oceanic islands (eg, United States Federal law 384-108 “Brown Tree Snake Control and Eradication Act of 2004”). In other words, even from case histories, generalizations can sometimes be made.
There can also be real reasons to ignore the issue of generality. One benefit of specificity is experimental control. Transgenic lines may differ by single gene knockout or by gene duplication, and clearly the aim of such studies is to evaluate the function (hence purpose) of the gene product (or its absence) on some phenotype. In this sense it may not seem important that an transgenic mouse is not representative of a wild outbred mouse population. However, this argument is fundamentally one of expedience — such studies do result in specific results, results that cannot be generalized beyond the strains involved. It ignores the issue of genetic background — all of the genes that affect a trait in addition to the candidate gene under study (Sigmund 2000; Lariviere et al 2001). Transgenic mice of different inbred strains or their hybrids may have very different alleles at other genes that may influence a phenotype, hence, the results of the gene knockdown or other engineering result in different outcomes. Results of genetic manipulations on inbred strains, no matter how sophisticated, the conclusions are strain- or hybrid cross-specific. Thus, although technically and financially difficult, conclusions are better, more generalizable, when conducted with many different inbred lines and verified in outbred mouse populations precisely because genetic background often influences function of single genes (Sigmund 2000; Lariviere et al 2001).
“Causal criteria:” Logic of causation in medicine.
This section is in progress. Just a list of key points and references
Throughout this text, emphasis on the power of experimentation is emphasized. Well designed experiments …
Henle-Koch’s postulates (1877, 1882), working on tuberculosis reported a set of causal criteria to establish link between a microorganism and a disease, are the following:
- The microorganism must be found in abundance in all organisms suffering from the disease, but should not be found in healthy organisms.
- The microorganism must be isolated from a diseased organism and grown in pure culture.
- The cultured microorganism should cause disease when introduced into a healthy organism.
- The microorganism must be reisolated from the inoculated, diseased experimental host and identified as being identical to the original specific causative agent.
Robert Koch wrote these more than 100 years ago, so, clearly, understanding of infectious disease has improved. Evan’s postulates, quoted from A Dictionary of Epidemiology, 5th edition (pp. 86-87).
- Prevalence of the disease should be significantly higher in those exposed to the hypothesized cause than in controls not so exposed.
- Exposure to the hypothesized cause should be more frequent among those with the disease than in controls without the disease—when all other risk factors are held constant.
- Incidence of the disease should be significantly higher in those exposed to the hypothesized cause than in those not so exposed, as shown by prospective studies.
- The disease should follow exposure to the hypothesized causative agent with a normal or log-normal distribution of incubation periods.
- A spectrum of host responses should follow exposure to the hypothesized agent along a logical biological gradient from mild to severe.
- A measurable host response following exposure to the hypothesized cause should have a high probability of appearing in those lacking this before exposure (eg, antibody, cancer cells) or should increase in magnitude if present before exposure. This response pattern should occur infrequently in persons not so exposed.
- Experimental reproduction of the disease should occur more frequently in animals or humans appropriately exposed to the hypothesized cause than in those not so exposed; this exposure may be deliberate in volunteers, experimentally induced in the laboratory, or may represent a regulation of natural exposure.
- Elimination or modification of the hypothesized cause should decrease the incidence of the disease (eg, attenuation of a virus, removal of tar from cigarettes).
- Prevention or modification of the host’s response on exposure to the hypothesized cause should decrease or eliminate the disease (eg, immunization, drugs to lower cholesterol, specific lymphocyte transfer factor in cancer).
- All of the relationships and findings should make biological and epidemiological sense.
Fredericks, D. N., & Relman, D. A. (1996). Sequence-based identification of microbial pathogens: a reconsideration of Koch’s postulates. Clinical microbiology reviews, 9(1), 18-33.
Correlation (association) does not imply causation, a well-worn truism in any application of critical thinking skills. Conversely, causation does imply association (correlation); If a change in one variable directly changes another variable, there will be a statistical association between the two variables. Thus, a correlation between two variables is necessary, but not sufficient evidence for cause and effect between two variables.
Note 4: Association is the more general term for a possible relationship between two or more variables. A correlation in statistics generally refers to a linear association (Chapter 16); the aforementioned truism should be restated as association (or statistical relationship) does not imply causation.
However, sometimes association does point to a cause. A familiar example is association between tobacco cigarette smoking causes lung cancer. Surgeon General Luthar Terry’s 1964 report (link to document in National Library of Medicine), presented a strong case linking smoking to elevated risk of lung cancer and coronary artery disease.
Bradford Hill’s guidelines to evaluate causal effects based on epidemiology (Hill 1965, see also Sussar 1999, Fedak et al 2015). Set of necessary and sufficient conditions, inductive reasoning.
- Strength of association
- Consistency of observed association
- Specificity of association
- Temporal relationship of the association
- Biological gradient, eg, a dose-response curve
- Biological plausibility
- Coherence, the cause and effect inference should not conflict with what is known about the etiology of a disease.
Follows and extends David Hume’s (1739) causation criteria: association (Hill #1), cause precedes effect (Hill #4), direction of connection.
Validity.
An obvious objective of research is to reach valid conclusions about fundamental questions. A helpful distinction between the specific and the generalizable experiment is to recognize there are two forms of validity in research: internal validity and external validity (Elwood 2013). Internal validity is the quality of a designed study that determines whether cause and effect can be determined. Random assignment of subjects to treatment groups enhances the internal validity of the study. External validity relates to how general the assessment of cause and effect can be to other populations. Thus, random sampling from a reference population has to do with whether or not the study has external validity.
Additional definitions.
We proceed now with definitions. We use the term population in a special and restrictive way in statistics. Our definition includes the one you are already familiar with, but it also means more than that.
Populations are the entire group of individuals that you want to investigate. In statistics, the entire groups is actually the entire class with the observation — so if we are referring to the average body weight of house mice, we’re actually referring to the body weight as the population — it’s a subtle distinction, not essential for our introduction to biostatistics. When we conduct experiments and apply statistical tests on collected data, we generally intend to make inferences (draw conclusions) from our results back to the population.
Population has a strict application in statistics, but the definition also includes our general understanding of the word population. For example, Examples of a population in the general sense one may refer to include: .… the entire human population existing today .… the entire collection of U.S. citizens. .… all the individuals in an entire species. .… all individuals in a population of a species (eg, house mice in a dairy barn in Hawai’i) .… all of us in this classroom (if we are ONLY interested in US) If you could measure the entire population then there would be no need to do (or learn) statistics! Populations usually are in the thousands, millions, or billions of individuals. Here, population is used in the everyday sense that we think of — a collection of individuals that share a characteristic.
A more formal definition of “population” in statistics reads as follows: A statistical population is the complete set of possible measurements on a trait or characteristic corresponding to the entire collection of sampling units for which conclusions are intended.
To conclude, in this class, when we talk about population, we will generally be using it in the everyday sense of the word. However, keep in mind that the definition is more restrictive than that and the key is to identify what sampling units are measured.
Conclusions.
This is only the beginning, the basics of experimental design. Beginning with RA Fisher‘s 1935 book, The Design of Experiments (nine editions, some freely accessible via internet search), which is still very much worth reading, entire books are written on the subject, as you can well imagine.
Note 5: Fisher’s The Design of Experiments concerned experimental design, randomization, blocking, and replication, particularly from perspective of agriculture research. Most readers of this eBook likely know that RA Fisher’s broader career absolutely included eugenics and hereditarian views about human populations and race. Those views are not in The Design of Experiments, which is largely about methods and statistical framework for inference.
We will also return to the subject of Experimental Design throughout the book. We will return to random sampling in Chapter 5.5. Next we discuss distinctions between experiments and observational studies with respect to sampling of populations.
A bit of a disclaimer here before proceeding; while I cite several papers for examples in experimental design in Chapter 5, reader’s should not read into this that I am either criticizing or endorsing the published experiments. Experimental design will always have elements of compromise — the trick of course is knowing which choices influence validity (Thompson and Panacek 2006).
Questions.
- Define in your own words the following terms
- reference population
- subjects
- specific versus general conclusions
- random sampling
- convenience sampling
- haphazard sampling
- research validity
- Revisit our cell experiment, “What is the sampling unit in the following cell experiment?” How would you change this experiment so that there will be biological and not just technical replication?
- Describe the type of sampling for each research scenario described?
- All African snails on a staircase at Chaminade University are collected on a Thursday evening.
- All African snails on a staircase at Chaminade University are collected every Thursday evening for six months.
- All African snails on all staircases at Chaminade University are collected.
- African snails are studied in the lab, then returned to the areas from which they were collected. Days later, the researcher collects snails from the same area.
- African snails are studied in the lab, then returned to the areas from which they were collected. Days later, the researcher collects snails from a different area.
- The Chaminade University campus is divided into grids. Grids that include stairwells are marked. Before collecting snails, the researcher randomly selects from the list of grids and searches for snails only in those grids selected from the list.

Figure 1. Giant African Snail (Lissachatina fulica, formerly Achatina fulica). Image by M. Dohm.
- This next scenario may be evaluated by you for potential sources of bias. Review the list of bias listed above. A researcher wants to do a population count of feral cats on campus. Feral cats are active at night, so he decides to set up a feeding station near a light post. The researcher sits all night in a parked car yards away and watches the feeding station for visits by cats. The researcher repeats these observations over the course of a week, moving the feeding station to different campus locations each night, and reports the total number of cats seen during the week as an estimate of the population size. Be able to discuss this study in terms of potential and actual bias.
Quiz
Including the quiz on this page, a total of 65 questions among the several subchapters, a mix of true or false and multiple choice question format.
Quiz Chapter 5
Experimental design
Chapter 5 contents
2.4 – Experimental Design and rise of statistics in medical research
Experiments and observations: Finding answers.
.
How to identify cause and effect, and the kinds of evidence that can be inferred from the various approaches to study causes of disease has became a major source of disagreement in the news. In a fascinating study, Pew Research Center reported “half of U.S. adults under 50 say they get health and wellness information from social media influencers or podcasts,” and, only about 17% of these influencers report “conventional medicine” training (Report, May 7 2026). For our purposes, I made substantial updates to this page in the fifth month after WHO had declared the Covid-19 pandemic (CDC timeline), and continue to do so today.
The pandemic left many life-lessons, for scientists and public-health supporters, but also for everyone who lived through those times. One of the lessons was how to deal with the challenges of finding treatments in real time. If you followed the news early in the pandemic, you know of the appeal from some (including Donald Trump, the then-President of the United States, Boseley 2020), for use of an anti-parasite drug, hydroxychloroquine, as prophylactic or treatment for active Covid-19 infection (cf. Liu et al 2020). The FDA as well as other institutions rapidly advised against use, in part because experimental design concerns were raised for early studies (Kupferschmidt, 2020). The issue remains contentious for some (eg, Health and Human Services Secretary Robert F. Kennedy Jr., CNN August 2, 2026 interview).
Thus, job number one for students of biostatistics is to learn how to weigh arguments for or against therapies or treatments offered. The purpose of this page is to introduce these issues — how to judge whether a treatment is effective or not.
We will spend some time later on statistical aspects of experimental design (Chapter 5), but we begin with Randomized Control Trials, or RCT, as a model for our discussion of experimental studies. The RCT we recognize today owes its beginning to the 1948 studies on streptomycin use to treat tuberculosis (British Medical Research Council 1948), but of course, the foundations of RCT and experimental design in general, go back much earlier than that date (Chalmers 2011, Hairton and Locascio 2018). For a number of reasons the RCT — experimental, prospective, double-blind clinical trial with random selection of subjects from a reference population and random assignment of subjects to a treatment group or an appropriate placebo treatment control group — is considered the “gold standard” method for producing knowledge (Kaptchuk 2001, Hairton and Locascio 2018).
Note 1. I use the phrase “gold standard” associated with the RCT in the historical context intended by the authors cited. Unfortunately, in 2025, the phrase “gold standard science” has become political (Lewandowsky 2025, Mervis 2025). What we can agree on is characteristics of research as good science: “reproducible; transparent; communicative of error and uncertainty; collaborative and interdisciplinary; skeptical of its findings and assumptions; structured for falsifiability of hypotheses; subject to unbiased peer review; accepting of negative results as positive outcomes; and without conflicts of interest,” Sec. 3. Restoring Gold Standard Science, Presidential Executive Order, May 23, 2025. But even this list is not above scrutiny.
This discourse is way above my pay grade, but for starters, I would replace “without conflicts of interest” with “without disclosure of potential conflicts of interest.” The latter is practical, the former is likely not at all achievable. After all, even where a conflict exists, it does not immediately follow that the reported science is bad, that the conflict is evidence by itself of bias. Reporting conflicts warns the reader that results and conclusions may warrant further scrutiny, but outright dismissal is itself contrary to good science practice. Certainly, there are other aspects to defining what is and what is not good science. And, “gold standard” is just a metaphor (Love 2003), and, frankly, a very out-dated one. The United States and most other nations long ago gave up — for many good reasons — the gold standard as a monetary standard.
Technically, RCT are intervention trials, a specific application of the more general definition of an experiment. That is, the researchers tests a potential drug or therapy in people to observe its effect while holding other variables constant. Experimental studies imply that the researcher imposed treatments or controls onto subjects. The subjects are followed and outcomes are recorded. Thus, experiments by definition are also prospective studies — the outcome is recorded for subjects after some period of time. With a well-designed experiment, the researcher may have evidence to support the claim that, for example, Treatment A causes the outcome.
RCT applied to human health can have profound impact on lives.
The ALLHAT-LLT (JAMA, 2002) trial tested whether adding the cholesterol-lowering drug pravastatin to standard care would reduce heart attacks and deaths in people with high blood pressure and moderately high cholesterol. The study found no significant benefit compared to usual care, suggesting that statin therapy may not always provide extra protection in this group. Its results helped refine how doctors balance blood pressure and cholesterol treatment in heart disease prevention.
The Women’s Health Initiative (JAMA, 2002) trial tested the effects of combined estrogen and progestin therapy in healthy postmenopausal women. It found that while the therapy slightly reduced the risk of fractures and colon cancer, it increased the risk of heart disease, stroke, and breast cancer. These results transformed medical guidance by showing that hormone therapy should not be routinely used to prevent chronic disease in postmenopausal women.
The Du Toit et al. (NEJM, 2015) study showed that introducing peanut-containing foods early in life — rather than avoiding them — greatly reduced the risk of developing peanut allergies in high-risk infants. This landmark randomized trial changed how doctors think about food allergies, leading to new guidelines that encourage early introduction instead of avoidance.
And more recently, we have study reported by Deanfield et al (Lancet, 2025), which found that semaglutide reduced the risk of major adverse cardiovascular events (MACE) in adults with overweight or obesity and established cardiovascular disease—even if they did not lose much weight or had lower baseline adiposity.
In contrast, observational studies are those in which treatments arise by acts of nature. In both experiments and observational studies, there can be treatment and control groups; the distinction between the types of studies is how assignment of subjects to treatments were affected. Observational studies generally are retrospective studies — the outcome has already occurred, the researcher follows up to identify differences among the groups that may account for different outcomes. Examples of observational, retrospective study designs include cross-sectional and case control; cohort studies are prospective studies. Observational studies are discussed further in Chapter 5.4 – Clinical trials.
Compared to observational studies, in principle, experiments can establish cause and effect. Cause and effect refers to an explanation about relationship between two events or objects. In biology, Ernst Mayr (1904 – 2005) distinguished between two levels of explanation, proximate (how) explanations and ultimate (why) explanations (Mayr 1961, cf. Laland et al. 2011). As you know, our mechanism for identifying cause and effect is application of the Scientific Method (Chapter 2.5). Discussions of how to detect cause and effect are provided throughout this book, but emphasized in a few sections (Chapter 16.2 and 16.3).
Good experiments.
The principles of good experiments include many steps beyond simply choosing treatments and controls. In Chapter 5 we’ll go into more depth, but I wished to list for you some of the key principles of good experimental design. With respect to human-subject research, the researcher needs to protect against many sources of potential bias.
- Randomization of subjects assigned to treatment groups controls for individual differences.
- Controls (eg, Placebos) are a means to establish controls in a study so that effects may be attributed to the active treatment.
- Single-blind implies that the subject does not know what treatment was given.
- Double-blind implies that not only is the subject unaware of the treatment received, but, crucially, neither does the researcher.
- The double-blind design — neither the patient-subject nor the researchers know who received the placebo or the treatment — controls for subtle biases.
Note 2. Experimental control implies researcher imposes conditions to remove possibly confounding effects on the dependent variable — outcome of the experiment. Placebo, derived from Latin placere, to please (but see Aronson 1999). Placebo refers to an inert substance (“sugar pill”), or to a substance with known activity but without effect on the target condition or “wrong indication” (eg, antibiotics administered for viral infection), given to research subjects in lieu of the active treatment of interest (the hypothesis). Thus, placebos are examples of treatment controls.
The placebo effect is improvement of subjects who received the placebo and not active treatment (Pardo-Cabello et al 2022). In contrast, nocebo effects are adverse effects attributed to placebo treatment. Under most circumstances, placebo applies to humans only because placebo effects are thought to be product of psychological factors, although mechanisms of action are in dispute. Is sentience necessary for a placebo effect (cf. McMillan 1999)?
The experimenter may influence the outcome of the experiment if knowledge about who received the placebo or the new drug; the subject may respond differently with knowledge that they received the placebo and not the new drug. The key intent in this experimental design is to avoid systematic error, errors in studies that may occur because of our conscious and unconscious beliefs and biases. Placebos are used as treatments because people (and animals!) sometimes get better (or worse) with or without treatment; thus, to be effective, subjects receiving a new drug must get better more frequently than do subjects on placebo. Importantly, the well-designed placebo allows the researcher to gain insight into the mechanism of action by the new drug.
A case to consider: Comparing migraine treatments.
.
Consider the following experiment (Diener et al 2006; see also Liu et al 2018): subjects who had several migraines per month were treated with acupuncture, sham-acupuncture, or standard treatments including beta blockers, calcium channel blockers, or antiepileptic drugs. After 26 weeks the reductions in reported migraines was compared. The authors reported that there was no difference in numbers of migraines among patients who received the different therapy treatments. The authors conclude that because acupuncture lacks side-effects that may occur with standard therapies acupuncture may be a good choice for patients seeking relief from migraine. This is a classic experiment — subjects were assigned to treatments by the researchers. At least in principle, if one treatment group showed better outcomes, the improvement could be attributed to the treatment.
Another case to consider: When the cause isn’t clear.
.
Consider the following example. My dad was diagnosed with lung cancer in his late 70s; his left lung showed many spots when imaged and biopsy confirmed. Surgeons removed half of the lung and after several years he was considered cancer free. Why did he develop cancer in the first place? If you immediately think, “He’s a smoker,” that’s not a good explanation — and shame on you, you’re first instinct was to blame the patient (see discussion in Huff 2013). Dad last smoked tobacco in his early thirties (latency smoking-lung cancer link about 20 years, Lipfert et al 2019).
Tobacco smoking is not the only environmental trigger for lung cancer. Cancer of the lung in non-smokers is the seventh leading cause of cancer mortality worldwide (Field and Withers 2012). Long term exposure to radon gas, a naturally occurring, radioactive noble gas has been linked to lung cancer (EPA). I grew up on Vashon Island, Washington, in a non-smoking home environment. Radon levels on Vashon Island and other areas around Puget Sound are low (source: Washington State Department of Health). Radon is out as an explanation.
What other environmental sources may be linked to cancer? Vashon Island is rural, but, as it turned out, within range of effluent from a copper smelter located in nearby Ruston, Pierce County (Fig 1; my home was 17 km distance from the smelter).

Figure 1. Left: ASARCO smelter, Ruston, Washington, image from Department of Ecology, State of Washington. Direction of smoke from the stack is north, toward Vashon Island. Right: Voronoi map of arsenic and lead affected areas. image from kingcounty.gov. Darker regions correspond to heavier arsenic and lead contamination of soils.
The smelter was last in operation in 1986 and was torn down in 1993 (EPA publication number 910R94001). The smelter stack rose more than 500 feet dispersing smoke laden with heavy metals, notably inorganic arsenic and lead, into the air (Bromenshenk et al. 1985). Over the smelter’s 68 years of service, winds carried away the smoke to my island and to other areas known now as the “Ruston-Vashon Island Exposure Pathway” (Kalman et al 1990). The former smelter site was among the first listed Superfund sites (1983) in the United States by the EPA. Thus, tens of thousands of people were (and continue to be) exposed to the heavy metals deposited into the soils, forming a distinct exposure group (Milham & Strong 1974; Kalman et al 1990; EPA 2000). Arsenic exposure can be via inhalation, skin, or in drinking water — areas of Vashon-Maury island continue to have high levels of arsenic in both the soil and in any domestic water wells (PublicationNo. 14-09-044, Department of Ecology State of Washington).
Note 3: A personal comment — I stumbled onto the article by Bromenshenk and colleagues by accident. Instead of attending lecture, as I often did at the time, I was looking through journals in the research library. I was shocked at this article, because for the first time, I connected the smelter to the island I grew up on. The contamination on the island just wasn’t a conversation.
Is arsenic exposure by inhalation a plausible mechanism for my Dad’s lung cancer? As shown in Fig 1, the soils on Vashon near my home were heavily impacted by the smelter. Exposure could have come about from exposure during routine yard work — I have memories of clouds of dust kicked up by the lawn mower during spring and summers. Thus, an exposure route is possible. What evidence can we come up with?
Figure 2A shows negative association between lung and bronchial cancer incidence rates per 100L persons, adjusted for age, for several Washington state counties between 2000 and 2020 and distance from the smelter in Ruston. For comparison, Figure 2B shows no association between bladder cancer incidence rates per 100K for the same counties and time period and distance from the smelter. Workers exposed to arsenic have higher rates of lung cancer (Sullivan 2007, Wei et al 2019; see Enterline et al 1987 for a study a study based on cancer of workers at the smelter). Cultured lung cells exposed to arsenic associated with changes in gene expression (Clancy et al 2012). Coincidently, two of the family dogs developed and died of cancer as did one female goat. Perhaps my dad’s lung cancer was attributed to long exposure to arsenic (a decade after the cancer, and long after he stopped with yard work, his blood readings for arsenic were in the range of a modest 11 μg/L).

Figure 2. County cancer rates (A, lung and bronchial; B, bladder) from 2000 – 2020 vs distance in kilometers from ASARCO smelter, Ruston, WA. Data compiled from Washington Tracking Network (WTN). The counties were King (55 km), Kitsap (39.28 km), Pierce (38.48 km), San Juan ( 141.43 km), Snohomish (100.73 km), and Spokane (385.34 km).
If this scenario seems plausible, I hope you immediately recognize it as a case of confirmation bias (see Chapter 2.6). Putting aside for a moment the different arsenic species, each with different LD50 (the lethal dose needed to kill half the population — see Chapter 20.10), the difficulty ascribing arsenic as a causal agent for my Dad’s cancer is that many other exposures happened simultaneously. For example, indoor carpets are a primary source of several volatile organic compounds (Haines et al 2020). Prior to 1980 carpets may have included formaldehyde and other known carcinogenic agents. Dad commuted by car between work and home — with a ferry ride between — for decades (until the early 1990s), routinely traveling heavily congested roadways, this during the years prior to and the early years of the Clean Air Act of Environmental Protection Agency of the United States (it wasn’t until 1981 that new cars met EPA emission standards: Clean Air Act timeline here). Thus, all commuters including my Dad were exposed to gasoline combustion emissions, many known to be carcinogenic (Parent et al 2007). Moreover, a limited study by Public Health of Seattle and King County (2001) found rates of cancer on Vashon between 1980 and 1988 were similar to other areas in King County.
Summary.
It’s easy to fall into the trap that experiments — and by extension meta-analysis and systematic reviews — are the best tools offered by science for developing knowledge about the world, and other approaches suffer by comparison. But after even a bit of reflection, we should recognize that it can’t be that simple. While we now “know” tobacco cigarette smoking increases lung cancer risk, and many experiments with animal models convincingly show the link (eg, Hutt et al 2005), no human experiment in the strict sense, ie, prospective, randomized control trial, has ever been conducted (hint: it would be unethical, see discussion in Allmark and Tod 2016). Instead, the accumulated evidence from observational studies on exposures of different populations over the years overwhelmingly points to smoking as a leading risk factor (cause) of lung and other cancers — an example of Hill’s guidelines of causality. We end with a quote:
RCTs can play a role in building scientific knowledge and useful predictions but they can only do so as part of a cumulative program, combining with other methods, including conceptual and theoretical development, to discover not ‘what works’, but ‘why things work’ (p 2, Deaton and Cartwright 2017).
Questions.
.
- Write up three learning outcomes for this page. Hint: Point your favorite generative AI to this page and ask for help.
- Was my Dad’s lung cancer attributable to his 40 years plus exposure to soil arsenic (he’s a non-smoker)? How should we approach this question?
- In Diener et al (2006), the authors concluded that because acupuncture lacks side-effects that may occur with standard therapies acupuncture may be a good choice for patients seeking relief from migraine. Do you agree with the authors?
- Ethical standards evolve with time. An ongoing debate in research is whether and how placebos are to be used in human subjects research. Placebos are a means to establish controls in a study so that effects may be attributed to the active treatment. The “gold standard” of clinical trials is considered to be the randomized double-blind design — neither the patient-subject nor the researchers know who receives the placebo or the treatment. Following review of the WHO report on Use of Placebos in Vaccine Trials, pick one study and evaluate whether or not the decision to use placebos was warranted in your opinion.
- I searched PUBMED for “double-blind” by decade and found the following results (August 2018) (Table 1). Open R and/or R Commander and create two variables, then generate a scatter plot. Describe the shape of the relationship between number of publications citing “double-blind” and time (eg, 1950 – 1959, 1960 – 1969, and so on).
| Decade | Publications |
|---|---|
| 1950 | 60 |
| 1960 | 995 |
| 1970 | 7184 |
| 1980 | 24737 |
| 1990 | 39643 |
| 2000 | 53965 |
| 2010 | 69265 |
- Here’s one way to enter this data into R. At the R prompt (or in the R Script window of R Commander), create two variables,
DecadeandPubsDecade <- c(seq(1950, 2020, by=10))Pubs <- c(59,995,7161,24728,39670,54011,57043)Make an XY scatter plotplot(Decade,Pubs) - Repeat the PUBMED search as above but search for “placebo”. Make a table like the one above and provide a scatterplot of your results.
- Is the concept of a placebo relevant if the subjects in your experiment are yeast cells, not humans?
- Similarly, if your subjects are yeast cells, how does the concept of performing experiments “blind” apply?
- Ethical standards change with time. An ongoing debate in research is whether and how placebos are to be used in human subjects research.
- If placebos are so important, why is their use a concern in clinical trials?
- Following review of the WHO report on Use of Placebos in Vaccine Trials (see Readings below), pick one study and evaluate whether or not the decision to use placebos was warranted in your opinion.
R notes for question 5:
<-is an assignment operator (assignOP); everything to the right of<-is assigned to the object named to the left of the<-operator. You can instead use=in place of<-, but because=is also used in other contexts besides assignment, a quick look at blogs by data scientists will find a preference to use<-for clarity and consistency.c()“combines” arguments into a vector.seq()is used to generate a sequence of numbers between a lower and an upper limit; ifby = nis included, the sequence will be increased by the value n. If omitted, then the sequence is increased by 1.
Quiz Chapter 2.4
Chapter 2 contents.
.
- Introduction
- Why biostatistics?
- Why do we use R Software?
- A brief history of (bio)statistics
- Experimental Design and rise of statistics in medical research
- Scientific method and where statistics fits
- Statistical reasoning
- Chapter 2 – References and suggested reading